Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia

Archives of General Psychiatry
D P van KammenJ L Peters

Abstract

We sought to identify haloperidol-treated subjects who relapsed within 6 weeks of placebo replacement and those who did not, using multivariate analysis. In the week prior to discontinuation of haloperidol treatment, global behavioral ratings and a lumbar puncture for cerebrospinal fluid monoamine metabolities were obtained in 88 patients with chronic schizophrenia. Logistic regression analyses were used to evaluate two competing models of relapse prediction. The models were then compared using receiver operating characteristic analysis and a final combined model was derived. The behavioral model was less variable in its prediction than the cerebrospinal fluid monoamine model. The final model consisted of increased psychosis, decreased anxiety, higher cerebrospinal fluid homovanillic acid levels, and lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels. Several monoamine systems are involved in psychotic relapse within 6 weeks of haloperidol withdrawal. Future studies of relapse prediction should include both clinical and biological measures to fully assess relapse risk.

Citations

Apr 1, 1997·Journal of Mental Health Administration·N S Lehrman, V H Sharav
Nov 11, 2008·Medical Education·Robert P DixonMartin S Humphreys
Nov 12, 2013·Schizophrenia Research·Gary RemingtonMargaret Hahn
Mar 31, 2006·Cognitive Neuropsychiatry·Kwang-Hyuk LeeEvian Gordon
Feb 13, 2001·Psychiatry Research·J K YaoD P van Kammen

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
D P van KammenJ L Peters
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
M E KelleyD P van Kammen
© 2021 Meta ULC. All rights reserved